Sign in

CIK 0001517022

  • Large accelerated filer

Akebia Therapeutics, Inc.

Sign in to watch
Ticker
AKBA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
208756903
Phone
+1 617-871-2098
Business address
180 THIRD AVENUE, FLOOR 2, WALTHAM, MA, 02451
  1. 4 Open-market sale SVP, Chief Business Officer sold 1,398 shares at $19.64 ($27,457)
  2. 4 Open-market sale SVP, Chief Business Officer sold 5,000 shares at $19.30 ($96,500)
  3. 4 Open-market sale SVP, Chief Business Officer sold 5,000 shares at $15.00 ($75,000)
  4. 4 Open-market buy Director bought 1,034,482 shares at $14.50 ($14,999,989)
  5. 4 Open-market sale SVP, Chief Business Officer sold 1,399 shares at $14.26 ($19,947)
  6. 4 Open-market sale SVP, General Counsel, Sec. sold 1,554 shares at $14.26 ($22,156)
  7. 4 Open-market sale Director sold 990 shares at $14.27 ($14,127)
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. 4 Open-market sale SVP, Chief Business Officer sold 1,401 shares at $9.18 ($12,858)
  18. 4 Open-market sale Director sold 991 shares at $9.20 ($9,119)
  19. 4 Open-market sale SVP, General Counsel, Sec. sold 1,556 shares at $9.18 ($14,280)
  20. 4 Grant or award SVP, Chief Business Officer acquired 39,500 shares (grant or award)

Page 13 of 19 · 378 filings